BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35051343)

  • 1. The diagnostic value of soluble TIM-3 in oral squamous cell carcinoma.
    Lu K; Ma H; Wang T; Huang Y; Ru M
    Future Oncol; 2022 Jan; ():. PubMed ID: 35051343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of serum synuclein-γ and squamous cell carcinoma antigen as diagnostic biomarkers in patients with oral squamous cell carcinoma and oral potentially malignant disorders.
    Chen L; Luo T; Yang J; Wang K; Liu S; Wei Y; Liu H; Xu J; Zheng J; Zeng Y
    J Oral Pathol Med; 2021 Feb; 50(2):165-174. PubMed ID: 33064859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic values of serum tumor markers Cyfra21-1, SCCAg, ferritin, CEA, CA19-9, and AFP in oral/oropharyngeal squamous cell carcinoma.
    Yuan C; Yang K; Tang H; Chen D
    Onco Targets Ther; 2016; 9():3381-6. PubMed ID: 27350753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of salivary levels of ErbB2 in oral squamous cell carcinoma.
    Jayarajkumar S; Ramamoorthi R; Muniapillai S; Gopalakrishnan S; Jayaseelan VP
    J Oral Maxillofac Pathol; 2023; 27(4):777. PubMed ID: 38304523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular Endothelial Growth Factor A (VEGF-A) and Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) as Potential Biomarkers for Oral Squamous Cell Carcinoma: A Sri Lankan Study.
    Edirisinghe ST; Weerasekera M; De Silva DK; Devmini MT; Pathmaperuma S; Wijesinghe GK; Nisansala T; Maddumage A; Huzaini H; Rich AM; De Silva H; Trudy M; Goonasinghe R; De Silva K; Yasawardena S
    Asian Pac J Cancer Prev; 2023 Jan; 24(1):267-274. PubMed ID: 36708576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical value of Naa10p and CEA levels in saliva and serum for diagnosis of oral squamous cell carcinoma.
    Zheng J; Sun L; Yuan W; Xu J; Yu X; Wang F; Sun L; Zeng Y
    J Oral Pathol Med; 2018 Oct; 47(9):830-835. PubMed ID: 30028540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of serum/salivary exosomal Alix in patients with oral squamous cell carcinoma.
    Nakamichi E; Sakakura H; Mii S; Yamamoto N; Hibi H; Asai M; Takahashi M
    Oral Dis; 2021 Apr; 27(3):439-447. PubMed ID: 32688445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated serum levels of a c-erbB-2 oncogene product in oral squamous cell carcinoma patients.
    Chen CH; Lin YS; Lin CC; Yang YH; Ho YP; Tsai CC
    J Oral Pathol Med; 2004 Nov; 33(10):589-94. PubMed ID: 15482324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of chemokine (C-X-C motif) ligand 9 (CXCL9) are associated with tumor progression and treatment outcome in patients with oral cavity squamous cell carcinoma.
    Chang KP; Wu CC; Fang KH; Tsai CY; Chang YL; Liu SC; Kao HK
    Oral Oncol; 2013 Aug; 49(8):802-7. PubMed ID: 23769451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of salivary matrix metalloproteinases- 12 (MMP- 12) levels among patients presenting with oral submucous fibrosis and oral squamous cell carcinoma.
    Saleem Z; Shaikh AH; Zaman U; Ahmed S; Majeed MM; Kazmi A; Farooqui WA
    BMC Oral Health; 2021 Apr; 21(1):205. PubMed ID: 33892690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum big endothelin-1 as a biomarker in oral squamous cell carcinoma patients: an analytical study.
    Mankapure PK; Barpande SR; Bhavthankar JD; Mandale M
    J Appl Oral Sci; 2015 Oct; 23(5):491-6. PubMed ID: 26537720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma.
    St John MA; Li Y; Zhou X; Denny P; Ho CM; Montemagno C; Shi W; Qi F; Wu B; Sinha U; Jordan R; Wolinsky L; Park NH; Liu H; Abemayor E; Wong DT
    Arch Otolaryngol Head Neck Surg; 2004 Aug; 130(8):929-35. PubMed ID: 15313862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SCCA, TSGF, and the Long Non-Coding RNA AC007271.3 are Effective Biomarkers for Diagnosing Oral Squamous Cell Carcinoma.
    Shao T; Huang J; Zheng Z; Wu Q; Liu T; Lv X
    Cell Physiol Biochem; 2018; 47(1):26-38. PubMed ID: 29763905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Salivary LINC00657 and miRNA-106a as diagnostic biomarkers for oral squamous cell carcinoma, an observational diagnostic study".
    Tarrad NAF; Hassan S; Shaker OG; AbdelKawy M
    BMC Oral Health; 2023 Dec; 23(1):994. PubMed ID: 38087258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring carcinogenesis in a case of oral squamous cell carcinoma using a panel of new metabolic blood biomarkers as liquid biopsies.
    Grimm M; Hoefert S; Krimmel M; Biegner T; Feyen O; Teriete P; Reinert S
    Oral Maxillofac Surg; 2016 Sep; 20(3):295-302. PubMed ID: 26875085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of Life Assessment With European Organisation for Research and Treatment of Cancer Questionnaire (Head and Neck Module 43) and Its Clinicopathological Correlation Among Patients Treated for Oral Squamous Cell Carcinoma: An Exploratory Study.
    Ramalingam K; Krishnan M; Ramani P; Muthukrishnan A
    Cureus; 2023 Feb; 15(2):e34650. PubMed ID: 36895543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary biomarkers for early detection of oral squamous cell carcinoma (OSCC) and head/neck squamous cell carcinoma (HNSCC): A systematic review and network meta-analysis.
    Khijmatgar S; Yong J; Rübsamen N; Lorusso F; Rai P; Cenzato N; Gaffuri F; Del Fabbro M; Tartaglia GM
    Jpn Dent Sci Rev; 2024 Dec; 60():32-39. PubMed ID: 38204964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and Validation of PLOD2 as an Adverse Prognostic Biomarker for Oral Squamous Cell Carcinoma.
    Sun Y; Wang S; Zhang X; Wu Z; Li Z; Ding Z; Huang X; Chen S; Jing Y; Zhang X; Ding L; Song Y; Sun G; Ni Y
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of Synuclein-
    Yang J; Pan Y; Peng L; Zhang L; Zhao J; Zheng Z; Zheng J; Xu X; Zeng Y
    Biomed Res Int; 2022; 2022():6534626. PubMed ID: 35434126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing Genomic Landscapes of Oral and Cutaneous Squamous Cell Carcinoma of the Head and Neck: Quest for Novel Diagnostic Markers.
    Gupta R; Strbenac D; Satgunaseelan L; Cheung VK; Narayanappa H; Ashford B; Mitchell J; Thind A; Palme CE; Ch'ng S; Low TH; Wykes J; Willet CE; Chew T; Yang J; Ranson M; Clark JR
    Mod Pathol; 2023 Aug; 36(8):100190. PubMed ID: 37080394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.